glp-1 type 2 diabetes Receptor Agonists and Research to Treat Overeating and Substance Use Disorders GLP-1 receptor agonists | How

As a new Citigroup report (the source of the previous two graphics) notes, there are more than a hundred new GLP-1 drugs in the pipeline that aim to be more convenient (as pills rather than injections), reduce side effects like nausea and muscle loss, or simply provide better weight-loss results

Reduces greasy fur, matting, and hair loss

Timing of brain changes Researchers have gained insight into the timing of these brain changes by studying longterm data from people with rare genetic mutations that virtually guarantee they will develop Alzheimer's disease

Garvey on CagriSema and the Future of Obesity Care Timothy Garvey, MD, of the University of Alabama at Birmingham, reviews the latest data on CagriSema and emerging amylin-based therapies presented at the 2026 ADA Scientific Sessions

What are the safety profiles and potential side effects of TESAMORELIN and CJC 1295

Effective treatment combines the right medication with ongoing education and support